Volume 0 - Multidisciplinary Cancer Investigation                   Multidiscip Cancer Investig 2025, 0 - Multidisciplinary Cancer Investigation: 47-50 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

haghighi M, ganjali A, heydari F, Haghighi G. Cancer overdiagnosis: The creation of disease in the modern world: A letter to the editor (Perspective). Multidiscip Cancer Investig 2025;
URL: http://mcijournal.com/article-1-417-en.html
1- Faculty of Zabol University of Medical Sciences, Zabol, Iran
2- Food and Drug Deputy, Zabol University of Medical Sciences, Zabol, Iran , abbasganjali1363@gmail.com
3- Faculty Affairs Expert, Vice of Education, Zabol University of Medical Sciences, Zabol, Iran
4- Assistant Professor of Traditional Medicine, Department of Internal Medicine, School of Medicine, Zabol University of Medical Sciences
Abstract:   (1129 Views)
One of the unavoidable harms of cancer screening is overdiagnosis, that is, the diagnosis and identification of a disease that will not lead to symptoms or death during the patient's lifetime. The critique of overdiagnosis is not just a critique of a scientific error, but a critique of a civilizational paradigm that has turned health into a commodity and humans into customers. The future of medicine depends on returning to a wise perspective that sees humans as (Transcendent beings in the process of transcendence) rather than as (potential diseases) commodities. Modern medicine, by relentlessly expanding the scope of disease and, under the pretext of early diagnosis, redefining normal life and natural phenomena as "disorder" and "disease," results in the deprivation of peace and transforms society into a "sick society." It is no secret that new technologies in medical science have the potential to revolutionize the way health care is provided, but to what extent can overdiagnosis and the use of advanced technology to diagnose diseases that do not need to be diagnosed because they will not cause problems for individuals in the future control the individual and social dimensions of the issues? Therefore, we suggest that health policymakers design and implement any future cancer screening program with the utmost care, emphasizing minimizing the harms of overdiagnosis.
Full-Text [PDF 272 kb]   (464 Downloads)    
Select article type: Letters to the Editor | Subject: Prevention, Early Detection and Screening
Received: 2025/10/26 | Accepted: 2025/11/8 | ePublished: 2025/11/8

References
1. Gupta P, Gupta M, Koul N. Overdiagnosis and overtreatment: how to deal with too much medicine. Journal of Family Medicine and Primary Care. 2020;9(8):3815-9. [DOI:10.4103/jfmpc.jfmpc_433_20] [PMID] [PMCID]
2. Welch HG, Black WC. Overdiagnosis in cancer. Journal of the National Cancer Institute. 2010;102(9):605-13. [DOI:10.1093/jnci/djq099] [PMID] [PMCID]
3. Takano T. Overdiagnosis of juvenile thyroid cancer. European Thyroid Journal. 2020;9(3):124-31. [DOI:10.1159/000503323] [PMID] [PMCID]
4. Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. Bmj. 2015;350. doi: 10.1159/000503323. [DOI:10.1159/000503323] [PMID] [PMCID]
5. Marcus PM, Prorok PC, Miller AB, DeVoto EJ, Kramer BS. Conceptualizing overdiagnosis in cancer screening. Journal of the National Cancer Institute. 2015;107(4):djv014. [DOI:10.1093/jnci/djv014] [PMID] [PMCID]
6. Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD, et al. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nature Reviews Cancer. 2019;19(6):349-58. doi: 10.1038/s41568-019-0142-8. [DOI:10.1038/s41568-019-0142-8] [PMID] [PMCID]
7. Hewitt K, Son J, Glencer A, Borowsky AD, Cooperberg MR, Esserman LJ. The evolution of our understanding of the biology of cancer is the key to avoiding overdiagnosis and overtreatment. Cancer Epidemiology, Biomarkers & Prevention. 2020;29(12):2463-74. [DOI:10.1158/1055-9965.EPI-20-0110] [PMID]
8. Richman IB, Long JB, Soulos PR, Wang S-Y, Gross CP. Estimating breast cancer overdiagnosis after screening mammography among older women in the United States. Annals of internal medicine. 2023;176(9):1172-80. [DOI:10.7326/M23-0133] [PMID] [PMCID]
9. Vaccarella S, Li M, Bray F, Kvale R, Serraino D, Lorenzoni V, et al. Prostate cancer incidence and mortality in Europe and implications for screening activities: population-based study. bmj. 2024;386. [DOI:10.1136/bmj-2023-077738] [PMID]
10. García-Alamino JM, López-Cano M. Sobrediagnóstico (overdiagnosis) y sobretratamiento (overtreatment).¿Más es mejor? Cir Esp (Ed impr). 2022:793-4. [DOI:10.1016/j.ciresp.2022.06.013] [PMID]
11. Dushimova Z, Iztleuov Y, Chingayeva G, Shepetov A, Mustapayeva N, Shatkovskaya O, et al. Overdiagnosis and Overtreatment in Prostate Cancer. Diseases. 2025;13(6):167. [DOI:10.3390/diseases13060167] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb